title: Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
authors.affiliation: CNRS, Institut de Pharmacologie et de Biologie Structurale, Toulouse, F-31000 France. cuvillio@me.com
authors.forename: Olivier
authors.initials: O
authors.lastname: Cuvillier
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ader
authors.forename: Pierre
authors.initials: P
authors.lastname: Bouquerel
authors.forename: Leyre
authors.initials: L
authors.lastname: Brizuela
authors.forename: Bernard
authors.initials: B
authors.lastname: Malavaud
authors.forename: Catherine
authors.initials: C
authors.lastname: Mazerolles
authors.forename: Pascal
authors.initials: P
authors.lastname: Rischmann
mesh_terms: D017209:Apoptosis; D002518:Ceramides / Q000378:metabolism; D006801:Humans; D008246:Lysophospholipids / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015398:Signal Transduction; D013107:Sphingolipids / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives / Q000378:metabolism; D000099157:Sphingosine Kinase
chemical_list: D002518:Ceramides; D008246:Lysophospholipids; D017853:Phosphotransferases (Alcohol Group Acceptor); D013107:Sphingolipids; D013110:Sphingosine; D000099157:Sphingosine Kinase; C060506:sphingosine 1-phosphate